Presidential Greeting - American Society for Laser Medicine and ...
Presidential Greeting - American Society for Laser Medicine and ...
Presidential Greeting - American Society for Laser Medicine and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
patient basis <strong>for</strong> increased efficacy <strong>and</strong> safety of cutaneous laser<br />
treatments.<br />
#32<br />
A LED BASED IMAGING SYSTEM FOR<br />
OPTIMIZATION OF PHOTODYNAMIC THERAPY<br />
OF BASAL CELL CARCINOMA<br />
Rolf B. Saager, David J. Cuccia, Steven Saggesse,<br />
Kristen M. Kelly, Anthony J. Durkin<br />
Beckman <strong>Laser</strong> Institute <strong>and</strong> Medical Clinic, University of<br />
Cali<strong>for</strong>nia, Irvine, CA; Modulated Imaging, Inc., Irvine, CA<br />
Background: PDT offers the potential <strong>for</strong> enhanced treatment of<br />
BCC skin cancer without the detriments associated with current<br />
treatment methods: healthy tissue loss, scarring. Yet, PDT has<br />
still not achieved the consistent per<strong>for</strong>mance required to gain<br />
widespread clinical acceptance <strong>for</strong> treatment of skin cancer. One<br />
particular limitation is a lack of quantitative tools to per<strong>for</strong>m in<br />
vivo dosimetry that monitors the light dose during therapy. Even<br />
when dosimetry is used, lesion variability leads to treatment plans<br />
that are not optimum. To this end, we have developed a new<br />
quantitative imaging device that may enable optimized therapy.<br />
Study: Clinical imaging of BCC lesions was per<strong>for</strong>med using<br />
Spatial Frequency Domain Imaging (SFDI). SFDI can quantify<br />
spatially resolved absorption <strong>and</strong> reduced scattering coefficients.<br />
With knowledge of these properties, it is possible to address<br />
critical aspects of PDT dosimetry including: (1) therapeutic light<br />
dose within the affected tissue, (2) oxygen supply necessary to<br />
generate destructive radicals within the lesion <strong>and</strong> (3)<br />
photosensitizer distribution <strong>and</strong> uptake within the tissue. We<br />
present a device designed to address these aspects by: (1)<br />
determining the optical properties at the therapeutic wavelength,<br />
(2) deducing spatially resolved absorption values to determine<br />
blood oxygenation in the tissue microvasculature, <strong>and</strong> (3)<br />
quantifying fluorescence from the photosensitizer by<br />
compensating <strong>for</strong> native tissue properties.<br />
Results: Preliminary clinical study of nine lesions demonstrate<br />
that optical properties vary greatly both spatially (101%, 48%) <strong>for</strong><br />
absorption <strong>and</strong> reduced scattering, respectively, <strong>and</strong> from patient<br />
to patient (102%, 57%). Oxygenation maps may be generated at<br />
50-mm resolution. Fluorescence signals from the photosensitizer<br />
can be accurately converted to drug concentrations to within<br />
0.2 mg/L.<br />
Conclusion: These preliminary results indicate that this<br />
technique provides quantitative, non-invasive assessments<br />
which characterize lesions based on physiologic parameters<br />
that are inaccessible to clinicians. This technology may lead to<br />
the development of subject <strong>and</strong> lesion specific treatment<br />
strategies.<br />
#33<br />
<strong>American</strong> <strong>Society</strong> <strong>for</strong> <strong>Laser</strong> <strong>Medicine</strong> <strong>and</strong> Surgery Abstracts 11<br />
REFLECTION MODALITY CONTINUOUS-WAVE<br />
TERAHERTZ IMAGER FOR CANCER<br />
DEMARCATION<br />
Cecil Joseph, Anna Yaroslavsky, Thomas Goyette,<br />
Robert Giles<br />
University of Massachusetts, Lowell, MA<br />
Background: Continuous-wave terahertz imaging has the<br />
potential to offer a non-invasive <strong>and</strong> comparatively inexpensive<br />
technique <strong>for</strong> demarcating skin cancers. The implementation of a<br />
coherent room temperature detection scheme, which offers<br />
increased SNR, is critical to the eventual goal of implementing a<br />
continuous-wave terahertz imaging system that can delineate<br />
cancer margins.<br />
Study: The goal of this study was to construct a heterodyne<br />
receiver based imager at 1.39 THz, determine its resolution <strong>and</strong><br />
available signal-to-noise ratio, <strong>and</strong> demonstrate imaging of skin<br />
cancer specimens. CO 2 laser pumped far-infrared gas lasers were<br />
used as the terahertz sources <strong>for</strong> the experiments. A room<br />
temperature heterodyne detection scheme was designed <strong>and</strong><br />
implemented. The system was tested using resolution targets <strong>and</strong><br />
skin cancer specimens. Its resolution <strong>and</strong> signal-to-noise ratio<br />
(SNR), in reflection modality, were determined. The samples were<br />
scanned across the focal plane using a two axis motion controlled<br />
stage, <strong>and</strong> the on-axis reflection image was generated.<br />
Results: The system resolution was determined to be 0.5 mm. The<br />
SNR was determined to lie between 110 <strong>and</strong> 130 dB. Preliminary<br />
imaging data of cancer specimens show good correlation between<br />
the terahertz images <strong>and</strong> Hematoxylin & Eosin (H&E)<br />
histopathology.<br />
Conclusion: A coherent hetrodyne detection scheme significantly<br />
improves the SNR of continuous-wave terahertz imaging <strong>for</strong><br />
cancer demarcation.<br />
#34<br />
TEST METHODOLOGIES FOR ESTABLISHING<br />
SAFETY OF HOME-USE LASER BASED DEVICES<br />
David Sliney, Michail Smirnov, Stewart Wilson,<br />
Oldrich Laznicka, Oksana Bradley, Felicia Whitney,<br />
Gregory Altshuler, Ilya Yaroslavsky<br />
Fallston, MD; Palomar Medical Technologies, Burlington, MA<br />
Background: A number of home-use, laser-based devices <strong>for</strong><br />
treatment of various skin conditions either have been recently<br />
introduced to the marketplace or are in different stages of<br />
development. A common feature of these devices is the presence of<br />
a safety suite designed to enable safe operation of the device by the<br />
average person with no prior experience or training. This state of<br />
affairs highlights the need <strong>for</strong> <strong>for</strong>mulating realistic, universally<br />
accepted product safety requirements, reflected in an industrywide<br />
st<strong>and</strong>ard, such as IEC 60825. A Class 1C (conditional Class<br />
1) has been proposed <strong>and</strong> is currently under discussion by the<br />
respective technical groups. One important aspect of codifying the<br />
safety requirements <strong>for</strong> such devices is to define the most suitable<br />
testing techniques to ensure both compliance <strong>and</strong> practical safety<br />
of the device.<br />
Study: Two principal approaches to the test are considered: (1)<br />
clinical test (possibly with a mock-up device) attempting to<br />
reproduce real-life scenarios of the device use; <strong>and</strong> (2) an ex vivo<br />
<strong>and</strong>/or phantom test with a pre-<strong>for</strong>mulated set of quantitative<br />
criteria. Both types of tests have been conducted on a home-use,<br />
fractional non-ablative laser device (PaloVia, Palomar Medical<br />
Technologies, Inc.).<br />
Results: Ocular safety of the tested device has been demonstrated<br />
with both types of tests. Similarities <strong>and</strong> differences in the<br />
outcomes of the two types of testing, as well as their relative<br />
advantages <strong>and</strong> disadvantages <strong>for</strong> the purpose of laser safety<br />
st<strong>and</strong>ards, have been evaluated.<br />
Conclusion: Phantom test methodologies can be considered the<br />
preferred method to ensure compliance of the tested device with<br />
the requirements of the future per<strong>for</strong>mance st<strong>and</strong>ard.